PMC:7195088 / 27735-27956 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T138","span":{"begin":67,"end":75},"obj":"Disease"},{"id":"T139","span":{"begin":191,"end":199},"obj":"Disease"}],"attributes":[{"id":"A138","pred":"mondo_id","subj":"T138","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A139","pred":"mondo_id","subj":"T139","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Comparison of hydroxychloroquine vs. placebo for the prevention of COVID-19 in healthcare workers at risk. Double-blind RCT (NCT04328467, not yet recruiting). Primary endpoint: prevalence of COVID-19 (follow-up 12 weeks)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T368","span":{"begin":14,"end":32},"obj":"Chemical"}],"attributes":[{"id":"A368","pred":"chebi_id","subj":"T368","obj":"http://purl.obolibrary.org/obo/CHEBI_5801"}],"text":"Comparison of hydroxychloroquine vs. placebo for the prevention of COVID-19 in healthcare workers at risk. Double-blind RCT (NCT04328467, not yet recruiting). Primary endpoint: prevalence of COVID-19 (follow-up 12 weeks)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T208","span":{"begin":107,"end":158},"obj":"Sentence"},{"id":"T209","span":{"begin":159,"end":221},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Comparison of hydroxychloroquine vs. placebo for the prevention of COVID-19 in healthcare workers at risk. Double-blind RCT (NCT04328467, not yet recruiting). Primary endpoint: prevalence of COVID-19 (follow-up 12 weeks)."}